Products

What will AGI do for Bendazac lysine dihydrate?

This classification denotes the lysine-dihydrate form of a nonsteroidal antiinflammatory drug with the molecular formula C16H14N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G4AG71204O, chemically known as acetic acid, ((1-(phenylmethyl)-1h-indazol-3-yl)oxy)- but more generally known as bendazac, which bears US NIH Compound Identifier 2313. Bendazac most often comes in base, lysine, methyl ester, and sodium forms. European Medicines Agency schedules Bendazac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05708MIG. The term BENDAZAC is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 24, No. 11 1970, List 10). World Health Organization schedules bendazac in its Anatomical Therapeutic Chemical (ATC) Classification. BENDAZAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule bendazac lysine dihydrate under HS 29339990. As of Q4 2014, BENDAZAC LYSINE DIHYDRATE remains US FDA's Preferred Term for this commodity. SMILES: C1CCC(CC1)CN2C3CCCCC3C(N2)OCC(=O)O.C(CCN)C[C@@H](C(=O)O)N.O.O.